Obesity Drug Market to Hit $130 Billion by 2030
The obesity drug market is projected to reach $130 billion by 2030, highlighting significant growth potential in the pharmaceutical industry.
The obesity drug market could be worth $130 billion by 2030, according to Goldman Sachs.